Patents by Inventor Aaron McMurtray

Aaron McMurtray has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods and compositions for modulating ?-amyloid/?7-nAChR interactions
    Patent number: 11382875
    Abstract: Methods of modulating the interaction between ?-amyloid and ?7-nAChR are provided. Aspects of the methods include administering to the subject an effective amount of a naphthalene derivative active agent. Compositions and kits for practicing the subject methods are also provided. The methods, compositions and kits find use in treating a variety of applications, such as treating a subject for a neurodegenerative disease, e.g., Alzheimer's disease.
    Type: Grant
    Filed: April 5, 2018
    Date of Patent: July 12, 2022
    Assignees: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Collaborations Pharmaceuticals, Inc.
    Inventors: Aaron McMurtray, Julia Chung, Natalie Diaz, Sean Ekins
  • Methods and Compositions for Modulating Beta-Amyloid/Alpha7-nAChR Interactions
    Publication number: 20210093587
    Abstract: Methods of modulating the interaction between ?-amyloid and ?7-nAChR are provided. Aspects of the methods include administering to the subject an effective amount of a naphthalene derivative active agent. Compositions and kits for practicing the subject methods are also provided. The methods, compositions and kits find use in treating a variety of applications, such as treating a subject for a neurodegenerative disease, e.g., Alzheimer's disease.
    Type: Application
    Filed: April 5, 2018
    Publication date: April 1, 2021
    Inventors: Aaron McMurtray, Julia Chung, Natalie Diaz, Seari Ekins